Inventor · disambiguated record
Pierre Falardeau
Also filed as: FALARDEAU PIERRE
4 granted patents·4 pending applications·29 citations·filing 1992–2016
70Inventor score
Top patents by PatentIndex Score
8 records- 0184US7358241B2Compositions and methods comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditionsTHALLION PHARMACEUTICALS INC·Filed 2005·Granted Apr 15, 2008·5 cites·21 claims
- 0258US5389543ACloned genes encoding the D1 dopamine receptorUNIV DUKE·Filed 1992·Granted Feb 14, 1995·24 cites·30 claims
- 0349US2009170837A1Methods for treating ras driven cancer in a subjectTHALLION PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0446US9375411B2Uses and methods for the treatment of liver diseases or conditionsVERLYX PHARMA INC·Filed 2013·Granted Jun 28, 2016·0 cites·28 claims
- 0546US2009062255A1Tumor-targeting evaluation methodology and compounds related theretoTHALLION PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0643US2003100089A1Serine protease inhibitor and processes for the preparation thereofFiled 2002·Application pending·0 cites
- 0741US2003087830A1Low molecular weight components of cartilage, complexes of metals with amino acids, DI-peptides and analogs thereof; processes for preparation and therapeutic uses thereofFiled 2001·Application pending·0 cites
- 0840US9827211B2Uses and methods for the treatment of liver diseases or conditionsVERLYX PHARMA INC·Filed 2016·Granted Nov 28, 2017·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Pierre Falardeau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →